ACAD
34.36
+0.04
+0.12%
AEMD
5.56
+0.11
+2.02%
APRI
0.362
-0.021
-5.4308%
ARNA
1.68
0.00
0.00%
ATEC
0.31
-0.03
-8.82%
CNAT
1.93
0.00
0.00%
CRXM
0.171
0.00
0.00%
CYTX
2.19
0.00
0.00%
DXCM
92.09
+1.53
+1.69%
GNMK
8.8
+0.13
+1.50%
HALO
10.1
-0.2
-1.94%
ILMN
172.79
-0.96
-0.55%
INNV
0.45
-0.01
-2.17%
INO
9.14
+0.08
+0.88%
ISCO
2
+0.03
+1.52%
ISIS
57.56
0.00
0.00%
LGND
108.07
+1.25
+1.17%
LPTN
2.68
-0.5
-15.72%
MBVX
5.35
+0.24
+4.70%
MEIP
2.05
+0.01
+0.49%
MNOV
6.55
+0.08
+1.24%
MRTX
5.46
+0.04
+0.74%
MSTX
0.415
+0.001
+0.266%
NBIX
51.5
-0.03
-0.05%
NUVA
64.1
+0.59
+0.93%
ONCS
1.797
-0.033
-1.8087%
ONVO
4.01
-0.04
-0.99%
OREX
4.34
-0.07
-1.59%
OTIC
17.26
-0.05
-0.29%
QDEL
21.55
+0.24
+1.13%
RCPT
231.96
0.00
0.00%
RGLS
3.44
-0.03
-0.86%
RMD
67.32
-2.46
-3.53%
SPHS
3.89
-1.93
-33.16%
SRNE
6.96
+0.01
+0.14%
TROV
5.21
-0.2
-3.70%
VICL
4.1
-0.06
-1.44%
VOLC
18
0.00
0.00%
ZGNX
9.56
-0.04
-0.42%
ACAD
34.36
+0.04
+0.12%
AEMD
5.56
+0.11
+2.02%
APRI
0.362
-0.021
-5.4308%
ARNA
1.68
0.00
0.00%
ATEC
0.31
-0.03
-8.82%
CNAT
1.93
0.00
0.00%
CRXM
0.171
0.00
0.00%
CYTX
2.19
0.00
0.00%
DXCM
92.09
+1.53
+1.69%
GNMK
8.8
+0.13
+1.50%
HALO
10.1
-0.2
-1.94%
ILMN
172.79
-0.96
-0.55%
INNV
0.45
-0.01
-2.17%
INO
9.14
+0.08
+0.88%
ISCO
2
+0.03
+1.52%
ISIS
57.56
0.00
0.00%
LGND
108.07
+1.25
+1.17%
LPTN
2.68
-0.5
-15.72%
MBVX
5.35
+0.24
+4.70%
MEIP
2.05
+0.01
+0.49%
MNOV
6.55
+0.08
+1.24%
MRTX
5.46
+0.04
+0.74%
MSTX
0.415
+0.001
+0.266%
NBIX
51.5
-0.03
-0.05%
NUVA
64.1
+0.59
+0.93%
ONCS
1.797
-0.033
-1.8087%
ONVO
4.01
-0.04
-0.99%
OREX
4.34
-0.07
-1.59%
OTIC
17.26
-0.05
-0.29%
QDEL
21.55
+0.24
+1.13%
RCPT
231.96
0.00
0.00%
RGLS
3.44
-0.03
-0.86%
RMD
67.32
-2.46
-3.53%
SPHS
3.89
-1.93
-33.16%
SRNE
6.96
+0.01
+0.14%
TROV
5.21
-0.2
-3.70%
VICL
4.1
-0.06
-1.44%
VOLC
18
0.00
0.00%
ZGNX
9.56
-0.04
-0.42%
Home » Archive by Category

Xconomy

Evoke Pharma’s Stock Sinks on Stomach Drug’s Phase 3 Failure

July 18, 2016 – 8:30 am

Evoke Pharma is taking a hit in the markets after announcing a Phase 3 trial on a gastroinetestinal drug for diabetes patients failed to meet its goals. In early trading Monday, Evoke’s (NASDAQ:…

[[Click headline to continue reading.]]

The Pan-Cancer Screen: Still Early for Prime Time

July 18, 2016 – 6:19 am

Imagine you could go to your doctor once a year for a blood test that would detect nearly every common type of cancer at an early stage. If you had a positive result, some further testing could…

[[Click headline to continue reading.]]

Biotech Roundup: Hellos, Goodbyes, “Cures” Delays And Trial News

July 15, 2016 – 4:00 am

The week started on a reflective note. Our San Diego editor Bruce Bigelow penned a personal goodbye to entrepreneur Larry Bock, who died last week of pancreatic cancer at the age of 56. And then the…

[[Click headline to continue reading.]]

An Homage to Larry Bock, Who Had God’s Hand on His Shoulder

July 10, 2016 – 10:40 pm

When I told Larry Bock in an e-mail about four months ago that I had been diagnosed with cancer, the renowned San Diego life sciences investor asked if he might see me at UC San Diego’s Moores…

[[Click headline to continue reading.]]

Biotech Roundup: Fighting Addiction, Obama Precision, Juno Deaths & More

July 8, 2016 – 3:30 am

This week started with celebrations of America’s birthday, and it has been dominated—biotech-wise—by America’s government. The Obama administration continued its high-profile…

[[Click headline to continue reading.]]

Pernix Therapeutics Slashes Staff to Shake Up Sales Strategy

July 7, 2016 – 7:23 am

Pernix Therapeutics is slashing its headcount by more than 20 percent as the specialty pharmaceutical company tries to move toward profitability after a streak of acquisitions. Morristown, NJ-based…

[[Click headline to continue reading.]]

Recruitment Goal In Obama Precision Med Study: 1M in 3 or 4 Years

July 6, 2016 – 5:00 pm

The Obama administration’s push to sign up one million Americans for a long-term health study will start in New York, Pittsburgh, Chicago, and Tucson, AZ, top health officials said today….

[[Click headline to continue reading.]]

Biotech Roundup: Moonshots, Pink Slips, Gilead, Brexit & More

July 1, 2016 – 3:00 am

The word of the week was “moonshot,” as U.S. Vice President Joe Biden’s cancer initiative convened a summit in Washington, DC. At the gathering, Biden took verbal shots at scofflaw…

[[Click headline to continue reading.]]

New Bootstrap Fund Pulls Itself Up in World of Health IT Deals

June 30, 2016 – 9:07 am

Healthtech entrepreneur Parker Hinshaw and his wife Jean Balgrosky said they intended to take a step back when they founded Bootstrap Incubation near San Diego in the fall of 2012. They wanted to…

[[Click headline to continue reading.]]

Riding Moonshot, FDA Will Revamp Its Cancer Practice. To What End?

June 30, 2016 – 6:06 am

As part of a national cancer “moonshot” initiative led by Vice President Joe Biden, the FDA said Wednesday it would retool the way it evaluates cancer treatments and tests. But to what…

[[Click headline to continue reading.]]